Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
160 East 34th Street
New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Oncology Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
Status: Enrolling, Phase III
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Status: Enrolling, Phase I
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling, Phase III
Updated: 12/31/1969
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials